Reuters: Health
AstraZeneca Plc said on Tuesday that the U.S. Food and Drug Administration granted fast track status for the development of its diabetes drug Farxiga to prevent heart and kidney failure in patients with long-term kidney disease.
AstraZeneca says U.S. FDA grants fast track status for diabetes drug Farxiga
AstraZeneca says U.S. FDA grants fast track status for diabetes drug Farxiga
Reuters: Health
AstraZeneca Plc said on Tuesday that the U.S. Food and Drug Administration granted fast track status for the development of its diabetes drug Farxiga to prevent heart and kidney failure in patients with long-term kidney disease.
Reuters: Health
AstraZeneca Plc said on Tuesday that the U.S. Food and Drug Administration granted fast track status for the development of its diabetes drug Farxiga to prevent heart and kidney failure in patients with long-term kidney disease.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment